Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.
Häring HU, Merker L, Seewaldt-Becker E, Weimer M, Meinicke T, Woerle HJ, Broedl UC; EMPA-REG METSU Trial Investigators. Häring HU, et al. Among authors: seewaldt becker e. Diabetes Care. 2013 Nov;36(11):3396-404. doi: 10.2337/dc12-2673. Epub 2013 Aug 20. Diabetes Care. 2013. PMID: 23963895 Free PMC article. Clinical Trial.
Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
Manolis AJ, Reid JL, de Zeeuw D, Murphy MB, Seewaldt-Becker E, Köster J; ARAMIS Study Group. Manolis AJ, et al. Among authors: seewaldt becker e. J Hypertens. 2004 May;22(5):1033-7. doi: 10.1097/00004872-200405000-00027. J Hypertens. 2004. PMID: 15097245 Clinical Trial.